Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-07-034646
Filing Date
2007-07-02
Accepted
2007-07-02 11:47:07
Documents
1
Period of Report
2007-06-28

Document Format Files

Seq Description Document Type Size
1 v079876_ex.html 4  
1 v079876_ex.xml 4 3615
  Complete submission text file 0001144204-07-034646.txt   5385
Mailing Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address 350 CORPORATE BLVD ROBBINSVILLE NJ 08691 6092089688
NEXMED INC (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXMED, INC. 350 CORPORATE BLVD ROBBINSVILLE NJ 08691
Business Address (609) 208-9688
Oppenheim Leonard A (Reporting) CIK: 0001307647 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 07953643